(Q54189779)

26 May 2018

title

MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma. (English)

1 reference

26 May 2018

1 reference

Gang Shen

1

1 reference

26 May 2018

Xiaoxiang Rong

2

1 reference

26 May 2018

Jianbo Zhao

3

1 reference

26 May 2018

Xuewei Yang

4

1 reference

26 May 2018

Haibo Li

5

1 reference

26 May 2018

Hua Jiang

6

1 reference

26 May 2018

Qiang Zhou

7

1 reference

26 May 2018

Tianxing Ji

8

1 reference

26 May 2018

Sicong Huang

9

1 reference

26 May 2018

Jing Zhang

10

1 reference

26 May 2018

Hongyun Jia

11

1 reference

26 May 2018

language of work or name

English

0 references

publication date

3 October 2014

1 reference

26 May 2018

published in

Carcinogenesis

1 reference

26 May 2018

volume

35

1 reference

26 May 2018

issue

12

1 reference

26 May 2018

page(s)

2748-2755

1 reference

26 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Hepatocellular carcinoma in 2011 and beyond: from the pathogenesis to molecular targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The molecular pathogenesis and clinical implications of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Estimating the world cancer burden: Globocan 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Perturbations of the AKT signaling pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Activation of AKT kinases in cancer: implications for therapeutic targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The PKB/AKT pathway in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Unravelling the tumor-suppressive functions of FOXO proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The functions of animal microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The diverse functions of microRNAs in animal development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

miR-105 inhibits prostate tumour growth by suppressing CDK6 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

AKT signaling in normal and malignant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Insulin receptors in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Insulin receptor substrate 1 antisense expression in an hepatoma cell line reduces cell proliferation and induces overexpression of the Src homology 2 domain and collagen protein (SHC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

Cloning and increased expression of an insulin receptor substrate - 1-like gene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The role of insulin receptor substrate-1 in transformation by v-src

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU208

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGU208

1 reference

26 May 2018

1 reference

26 May 2018